Citius Oncology

Purcell & Lefkowitz LLP is investigating Citius Oncology (NASDAQ: CTOR) concerning possible breaches of fiduciary duty by Citius Oncology’s board of directors.

If you currently own Citius Oncology stock, and would like to receive more information regarding the investigation and your rights as a shareholder, free of charge, please fill out the form below.

*The submission of this form does not create an attorney-client relationship.